Product Information
OMEPRAZOLE DR 20 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0295 per EA under NDC 59651000205. Its NADAC has been published 417 times since Oct 10, 2018.
FDA first approved this application on Aug 19, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651000205
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OMEPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA203270FDA Approved
8/19/2015
TE Code
AB
On Market Since
8/19/2015
Pharmacological Classes
Price Statistics
The NADAC for OMEPRAZOLE DR 20 MG CAPSULE has been published 417 times since Oct 10, 2018, and over the history we have for it it has declined 26.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0295 per EA |
|---|---|
| All-time high | $0.0459 (Jul 10, 2019) |
| All-time low | $0.0265 (Nov 20, 2024) |
| 52-week high | $0.0316 |
| 52-week low | $0.0277 |
| Median price | $0.0351 |
| Average price | $0.0359 |
| Largest weekly change | -25.0% (Apr 17, 2024) |
| Weeks tracked | 417 |
| Tracking since | Oct 10, 2018 |
Generic Alternatives
The matcher finds 13 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Omeprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OMEPRAZOLE DR 20 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OMEPRAZOLE DR 20 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.0295 per EA (NDC 59651000205), effective Sep 30, 2026.
How has the price of OMEPRAZOLE DR 20 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OMEPRAZOLE DR 20 MG CAPSULE has declined 26.6%. It has been tracked across 417 weekly CMS publications since Oct 10, 2018.
What are the highest and lowest recorded NADAC prices for OMEPRAZOLE DR 20 MG CAPSULE?
Since Oct 10, 2018, the NADAC for OMEPRAZOLE DR 20 MG CAPSULE has ranged from a low of $0.0265 (Nov 20, 2024) to a high of $0.0459 (Jul 10, 2019), with a median of $0.0351 per EA.
Are there cheaper alternatives to OMEPRAZOLE DR 20 MG CAPSULE?
Yes. 13 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OMEPRAZOLE DR 20 MG CAPSULE, is $0.0277 per EA — about 6% below OMEPRAZOLE DR 20 MG CAPSULE.
Who manufactures OMEPRAZOLE DR 20 MG CAPSULE?
OMEPRAZOLE DR 20 MG CAPSULE (NDC 59651000205) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.